According to the research report, the global metagenomic sequencing market size is expected to touch USD 12.04 Billion by 2032, from USD 2.17 Billion in 2022, growing with a significant CAGR of 18.69% from 2023 to 2032.
Key Takeaways:
- North America region dominated the market and recorded more than 42% of the revenue share in 2022. It is predicted to hit a value of USD 2,577 million by 2032, growing at a CAGR of 17.37%.
- The services segment dominated the market in 2022 and is expected to reach a value of USD 3,945 million by 2032, growing at a CAGR of 17.90% between 2023 and 2032.
- The drug discovery segment dominated the market in 2022 and the market size is projected to hit around USD 2,641 million by 2032, progressing with a CAGR of 18.59% between 2023 and 2032.
- Eurofins Scientific, a global market player in genomics generated revenues from $5,110 million in 2019 to $7,607 million in 2021 with a 2Y CAGR of 21%.
- 85% of the total size of Eurofins' food and environmental testing businesses accounted for genomics, biopharma, IVD, and related activities reported as of 2021.
The metagenomic sequencing report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global metagenomic sequencing in conjunction with the geographical landscape of this vertical have also been included in this report.
The report offers intricate dynamics about different aspects of the global metagenomic sequencing market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global metagenomic sequencing during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).
Sample Link @https://www.precedenceresearch.com/sample/2819
Scope of the Metagenomic Sequencing Market
| Coverage | Details |
| Market Size in 2023 | USD 2.58 Billion |
| Market Size by 2032 | USD 12.04 Billion |
| Growth Rate from 2023 to 2032 | CAGR of 18.69% |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Segmentation | By Product and Services, By Technology, and By Application |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America and Middle East & Africa |
This study covers a detailed segmentation of the global metagenomic sequencing market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global metagenomic sequencing market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.
Key Players
- BGI Group
- DNAStar, Inc.
- Eurofins Scientific
- GENEWIZ
- Illumina, Inc.
- IntegraGen SA
- Macrogen, Inc.
- Microsynth AG
- Novogene Corporation
- NuGEN Technologies, Inc.
- Oxford Nanopore Technologies Ltd.
- PerkinElmer
- QIAGEN N.V.
- Thermo Fisher Scientific, Inc.
- Zymo Research Corporation
Market Segmentation
By Product and Services
- Reagents and consumables
- Tools
- Services
By Technology
- Shotgun Metagenomics Sequencing
- 16S rRNA Sequencing
- Whole Genome Sequencing & De Novo Assembly
- Metatranscriptomics
By Application
- Ecological & Environmental Metagenomics
- Clinical Diagnostics
- Drug Discovery
- Biofuel
- Industrial Applications
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Research Methodology
The research methodology adopted by analysts for compiling the global metagenomic sequencing report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.
During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.
For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global metagenomic sequencing market.
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments